Styl cytowania APA

Shindiapina, P., & Alinari, L. (2018). Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: Evidence to date and clinical utility. Ther Adv Hematol.

Styl cytowania Chicago

Shindiapina, Polina, i Lapo Alinari. "Pembrolizumab and Its Role in Relapsed/refractory Classical Hodgkin’s Lymphoma: Evidence to Date and Clinical Utility." Ther Adv Hematol 2018.

Styl cytowania MLA

Shindiapina, Polina, i Lapo Alinari. "Pembrolizumab and Its Role in Relapsed/refractory Classical Hodgkin’s Lymphoma: Evidence to Date and Clinical Utility." Ther Adv Hematol 2018.

Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..